<DOC>
	<DOCNO>NCT00419926</DOCNO>
	<brief_summary>The purpose study determine initial intensified enteric-coated mycophenolate sodium ( Myfortic ) dose regimen administer first six week post renal transplantation provide improved efficacy , similar safety profile , compare standard regimen Myfortic .</brief_summary>
	<brief_title>Evaluation Therapeutic Benefit Initial Intensified Dosing Regimen Mycophenolate Sodium Versus Standard Regimen Renal Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Males female , 18 65 year old First second time kidney transplant patient For female capable become pregnant , negative pregnancy test prior entry trial effective birth control trial 3 month stop trial medication Previous graft loss due immunological reason 1st year 1st transplant Multiorgan recipients previous transplant another organ , different kidney Recipients nonheartbeating donor Known hypersensitivity mycophenolic acid cyclosporine HIV positive Hepatitis B surface antigen positive History malignancy ( past 5 year ) Pregnancy plan pregnancy , lactating , unwillingness use effective contraception . Evidence severe liver disease Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Renal , Kidney , Intensified , Enteric-coated mycophenolate sodium , Transplant</keyword>
</DOC>